Abuse liability of flunitrazepam among methadone-maintained patients

Psychopharmacology

Volumn 140, Issue 4, 1998, Pages 486-495

  Farré, Magí ^a   Terán, María Teresa ^a   Roset, Pere N ^a   Mas, Marta ^a,d   Torrens, Marta ^b   Camí, Jordi ^c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Abuse liability; Benzodiazepine; Flunitrazepam; Methadone; Opioid abuse

Indexed keywords

BENZODIAZEPINE DERIVATIVE; FLUNITRAZEPAM; METHADONE; TRIAZOLAM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG ABUSE; DRUG MEGADOSE; EUPHORIA; HUMAN; MALE; METHADONE TREATMENT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SEDATION;

ADULT; ANTI-ANXIETY AGENTS; BLOOD PRESSURE; BODY TEMPERATURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FLUNITRAZEPAM; HEART RATE; HUMANS; MALE; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS;

EID: 0031647974     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050793     Document Type: Article

References (57)

1. Arendt RM, Greenblatt DJ, deJong RH, Bonin JD, Abernathy DR, Ehrenberg BL, Giles HG, Sellers EM, Shader IR (1993) In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution. J Pharmacol Exp Ther 227:98-106
2. Association of the British Pharmaceutical Industry (1994) Data sheet compendium. Datapharm Publication, London
3. Barnas C, Rossmann M, Roessler H, Reimer Y, Fleischacker WW (1992) Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference. J Clin Psychopharmacol 12:397-402
4. Bond A, Seijas D, Dawling S, Lader M (1994) Systemic absorption and abuse liability of snorted flunitrazepam. Addiction 89: 821-830
5. Busto U, Kaplan HL, Zawertailo L, Sellers EM (1994) Pharmacological effects and abuse liability of bretazenil, diazepam, and alprazolam in humans. Clin Pharmacol Ther 55: 451-463
6. Calhoum SR, Wesson DR, Galloway GP, Smith DE (1996) Abuse of flunitrazepam (Rohypnol) and other benzodiazepines in Austin and South Texas. J Psychoact Drugs 28: 183-189
7. Darke SG, Ross JE, Hall WD (1995) Benzodiazepine use among injecting heroin users. Med J Aust 162:645-647
8. DuPont RL (1988) Abuse of benzodiazepines: the problems and the solutions. Am J Drug Alcohol Abuse 14 [suppl 1]: 1-69
9. Eap CB, Finkbeiner T, Gastpar M, Scherbaum N, Powell K, Baumann P (1996) Replacement of (R)-methadone by a double dose of (R.S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptative changes in methadone pharmacokinetics. Eur J Clin Pharmacol 50: 385-389
10. Fap CB, Berstchy G, Powell K, Baumann P (1997) Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone. J Clin Psychopharmacol 17:113-117
11. Evans SM, Funderburk FR, Griffiths RR (1990) Zolpidem and triuzolam in humans: behavioural and subjective effects and abuse liability. J Pharmacol Exp Ther 255:1246-1255
12. Evans SM, Critchfield TS, Griffiths RR (1991) Abuse liability assessment of anxyolytics/hypnotics: rationale and laboratory lore. Br J Addict 86:1625-1632
13. Farré M, Camí J (1991) Pharmacokinetic considerations in abuse liability evaluation. Br J Addict 86:1601-1606
14. Farré M, De la Torre R, Llorente M, Lamas X, Ugena B, Segura J, Camí J (1993) Alcohol and cocaine interactions in humans. J Pharmacol Exp Ther 266:1364-1373
15. Farré M, Terán MT, Camí J (1996) A comparison of the acute behavioral effects of flunitrazepam and triazolam in healthy volunteers. Psychopharmacology 125:1-12
16. Grahnén A, Wennerlund P, Dahlström B, Eckernäs SA (1991) Interand intraindividual variability in the concentration-effect (sedation) relationship of flunitrazepam. Br J Clin Pharmacol 31:89-92
17. Haertzen CA (1974) An overview of the Addiction Research Center Inventory: an appendix and manual of scales. DHEW Pub. no. (ADM) 79. Department of Health Education and Welfare, Washington
18. Haertzen CA, Hickey JF (1987) Addiction Research Center Inventory (ARCI): measurement of euphoria and other drug effects. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, New York, pp 489-524
19. Hannington-Kiff JG (1970) Measurements of recovery from outpatient general anaesthesia with a simple ocular test. BMJ 3:132-135
20. Henningfield JF, Johnson RE, Jasinski DR (1987) Clinical procedures for the assessment of abuse potential. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, New York, pp 573-590
21. Hindmarch I (1980) Psychomotor function and psychoactive drugs. Br J Clin Pharmacol 10:189-209
22. Iguchi MY, Handelsman L, Bickel WK, Griffiths RR (1993) Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend 32:257-266
23. Ingum J, Bjorklund R, Bjorneboe A, Christophersen AS, Dahlin F, Morland J (1992) Relationship between drug plasma concentrations and psychomolor performance after single doses of ethanol and benzodiazepines. Psychopharmacology 107: 11-17
24. Ingum J, Pettersen G, Sager G, Morland J (1994) Relationship between unbound plasma concentrations and various psychomotor and subjective affects after intakes of diazepam and flunitrazepam. Int Clin Psychopharmacol 9: 115-121
25. Iribarne C, Berthou F, Baird S, Dreano Y, Picart D, Bail JP, Beaune P, Menez JF (1996) Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol 9:365-373
26. Kolb L, Himmelsbach CK (1938) Clinical studies of drug addiction. III. A critical review of the withdrawal treatments with method of evaluating abstinence syndromes. Am J Psychiatry 94:759-799
27. Korttila K (1975) The effects of diazepam, flunitrazepam and droperidol with an analgesic on blood pressure and heart rate in man. Arzneimittellforschung 25:1303-1306
28. Lamas X, Farré M, Camí J (1994a) Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers. J Pharmacol Exp Ther 268:1485-1492
29. Lamas X, Farré M, Llorente M, Camí J (1994b) Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI). Drug Alcohol Depend 35:203-209
30. Luurila H, Olkkola KT, Neuvonen PJ (1996) Interaction between erythromycin and the benzodiazepines diazepam and flunitrazepam. Pharmacol Toxicol 78:117-122
31. Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245-258
32. Mattila MAK, Larni HM (1980) Flunitrazepam: a review of its pharmacological properties and therapeutic use. Drugs 20: 353-374
33. McLeod DR, Griffiths RR, Bigelow GE, Yingling J (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Meth Instrum 14:463-466
34. McNair DR, Lorr M, Droppleman LF (1971) Profile of mood states. Educational and Industrial Testing Service, San Diego
35. Medicom (1995) Vademeeum Internacional. Medicom, Madrid
36. Navaratnam V, Foong K (1990) Adjunctive drug use among opiate addicts. Curr Med Res Opin 11:611-619
37. Patat A, Foulhoux P, Klein MJ (1996) Etude des effects résiduels sur l'equilibre de trois hypnotiques (loprazolam, flunitrazépam, triazolam) appréciés par l'analyse spectrale des oscillations posturales. Thérapie 41:443-447
38. Physician's Desk Reference (1995) Medical Economics Data, Montvale
39. Pond SM, Tong TG, Benowitz NL, Jacob P, Rigod J (1982) Lack of effect of diazepam on methadone metabolism in methadone-maintained addicts. Clin Pharmacol Ther 31:139-143
40. Preston KL, Griffiths RR, Stitzer ML, Bigelow GE, Liebson IA (1984) Diazepam and methadone interactions in methadone maintenance. Clin Pharmacol Ther 36:534-541
41. Preston KL, Griffiths RR, Cone EJ, Darwin WD, Gorodetzky CW (1986) Diazepam and methadone blood levels following concurrent administration of diazepam and methadone. Drug Alcohol Depend 18:195-202
42. Preston KL, Guarino JJ, Kirk WT, Griffiths RR (1989) Evaluation of the abuse liability of methocarbamol. J Pharmacol Exp Ther 248:1146-1157
43. Preston KL, Wolf B, Guarino JJ, Griffiths RR (1992) Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability. J Pharmacol Exp Ther 262:707-720
44. Roache JD, Griffiths RR (1985) Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability. J Pharmacol Exp Ther 234:120-133
45. Robin DW, Hasan SS, Lichtenstein MJ, Shiavi RG, Wood AJ (1991) Dose-related effect of triazolam on postural sway. Clin Pharmacol Ther 49:581-588
46. Rush CR, Higgins ST, Bickel WK, Hughes JR (1993a) Acute effects of triazolam and lorazepam on human learning, performance and subject ratings. J Pharmacol Exp Ther 264:1218-1226
47. Rush CR, Higgins ST, Hughes JR, Bickel WK (1993b) A comparison of the acute effects of triazolam and temazepam in healthy volunteers. Psychopharmacology 112:407-114
48. San L, Tato J, Torrens M, Castillo C, Farré M, Camí J (1993a) Flunitrazepam consumption among heroin addicts admitted for inpatient detoxification. Drug Alcohol Depend 32:281-286
49. San L, Torrens M, Castillo C, Porta M, De la Torre R (1993b) Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: results from cross-sectional studies in 1988-1990. Addiction 88:1341-1349
50. Sancibrian M, Serrano JS, Minano FJ (1991) Opioid and prostaglandin mechanisms involved in the effects of GABAergic drugs on body temperature. Gen Pharmacol 22 [suppl 2]: 259-262
51. Schmider J, Greenblatt DJ, von Moltke LL, Shader IR (1996) Relationship of in vitro data on drug metabolism to in vivo pharmacokinetics and drug interactions: implications for diazepam disposition in humans. J Clin Psychopharmacol 16: 267-272
52. Stitzer ML, Griffiths RR, McLellan AT, Grabowski J, Hawthorne JW (1981) Diazepam use among methadone maintenance patients: patterns and dosages. Drug Alcohol Depend 8: 189-199
53. Sullivan JT, Jasinski DR, Johnson RE (1993) Single-dose pharmacodynamics of diazepam and pentobarbital in substance abusers. Clin Pharmacol Ther 54:645-653
54. Varbe A, Olkkola KT, Neuvonen PJ (1996) Diltiazem enhances the effects of triazolam by inhibiting its metabolism. Clin Pharmacol Ther 59:369-375
55. Wechsler D (1958) The measurement and appraisal of adult intelligence. Williams & Wilkins, Baltimore
56. Woods JH, Winger G (1997) Abuse liability of flunitrazepam. J Clin Psychopharmacol 17 [suppl 2]:1S-57S
57. Wu D, Otton SV, Sproule BA, Busto U, Inaba T, Kalow K, Sellers EM (1993) Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone. Br J Clin Pharmacol 35:30-34